Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

被引:22
|
作者
Qi, Qi [1 ]
Wei, Yidan [1 ]
Zhang, Xin [1 ]
Guan, Jian [1 ]
Mao, Shirui [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
Ocular posterior segment; Non-invasive; Topical drug delivery; Nanocarriers; NANOSTRUCTURED LIPID CARRIERS; RETINAL-PIGMENT EPITHELIUM; CONTACT-LENSES; TRIAMCINOLONE ACETONIDE; PHYSIOLOGICAL BARRIERS; POLYMERIC MICELLES; TEAR FILM; NANOPARTICLES; EYE; SEGMENT;
D O I
10.1016/j.jconrel.2023.07.055
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vital factor that seriously threatens human vision health and quality of life, the treatment of which poses a great challenge to ophthalmologists and ophthalmic scientists. In particular, ocular posterior drug delivery in a noninvasive manner is highly desired but still faces many difficulties such as rapid drug clearance, limited permeability and low drug accumulation at the target site. At present, many novel non-invasive topical ocular drug delivery systems are under development aiming to improve drug delivery efficiency and biocompatibility for better therapy of posterior segment oculopathy. The purpose of this review is to present the challenges in the noninvasive treatment of posterior segment diseases, and to propose strategies to tackle these bottlenecks. First of all, barriers to ocular administration were introduced based on ocular physiological structure and behavior, including analysis and discussion on the influence of ocular structures on noninvasive posterior segment delivery. Thereafter, various routes of posterior drug delivery, both invasive and noninvasive, were illustrated, along with the respective anatomical obstacles that need to be overcome. The widespread and risky application of invasive drug delivery, and the need to develop non-invasive local drug delivery with alternative to injectable therapy were described. Absorption routes through topical administration and strategies to enhance ocular posterior drug delivery were then discussed. As a follow-up, an up-to-date research advances in non-invasive delivery systems for the therapy of ocular fundus lesions were presented, including different nanocarriers, contact lenses, and several other carriers. In conclusion, it seems feasible and promising to treat posterior oculopathy via non-invasive local preparations or in combination with appropriate devices.
引用
收藏
页码:191 / 211
页数:21
相关论文
共 50 条
  • [21] Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling
    Delgado-Charro, M. B.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2009, 19 (02) : 75 - 88
  • [22] Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs
    Shukla, Snehal K.
    Sarode, Apoorva
    Kanabar, Dipti D.
    Muth, Aaron
    Kunda, Nitesh K.
    Mitragotri, Samir
    Gupta, Vivek
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2021, 128
  • [23] Overcoming Treatment Challenges in Posterior Segment Diseases with Biodegradable Nano-Based Drug Delivery Systems
    Wu, Kevin Y.
    Joly-Chevrier, Maxine
    Akbar, Dania
    Tran, Simon D.
    PHARMACEUTICS, 2023, 15 (04)
  • [24] Advanced Nanomedicine Delivery Systems for Cardiovascular Diseases: Viral and Non-Viral Strategies in Targeted Therapy
    Chen, Qian
    Yu, Tong
    Gong, Jingyi
    Shan, Hongli
    MOLECULES, 2025, 30 (04):
  • [25] Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases
    Bisht, Rohit
    Mandal, Abhirup
    Jaiswal, Jagdish K.
    Rupenthal, Ilva D.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2018, 10 (02)
  • [26] Non-Invasive Topical Drug-Delivery System Using Hyaluronate Nanogels Crosslinked via Click Chemistry
    Choi, Hyunsik
    Kwon, Mina
    Choi, Hye Eun
    Hahn, Sei Kwang
    Kim, Ki Su
    MATERIALS, 2021, 14 (06)
  • [27] Nanotechnology-based non-invasive strategies in ocular therapeutics: Approaches, limitations to clinical translation, and safety concerns
    Chaudhari, Pinal
    Lewis, Shaila A.
    Ghate, Vivek
    CONTACT LENS & ANTERIOR EYE, 2025, 48 (02)
  • [28] Controlled non-invasive iontophoretic delivery of triamcinolone acetonide amino acid ester prodrugs into the posterior segment of the eye
    Santer, Verena
    Chen, Yong
    Kalia, Yogeshvar N.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 132 : 157 - 167
  • [29] Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport
    Fang, Fei
    Zou, Dan
    Wang, Wei
    Yin, Ying
    Yin, Tieying
    Hao, Shilei
    Wang, Bochu
    Wang, Guixue
    Wang, Yazhou
    MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2017, 76 : 1316 - 1327
  • [30] Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model
    Kaya, Shona
    Callan, Bridgeen
    Hawthorne, Susan
    PHARMACEUTICS, 2023, 15 (05)